A dibasic sodium phosphate, anhydrous CEP of the European Pharmacopoeia monograph is often referred to as a dibasic sodium phosphate, anhydrous Certificate of Suitability (COS). The purpose of a dibasic sodium phosphate, anhydrous CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of dibasic sodium phosphate, anhydrous EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of dibasic sodium phosphate, anhydrous to their clients by showing that a dibasic sodium phosphate, anhydrous CEP has been issued for it. The manufacturer submits a dibasic sodium phosphate, anhydrous CEP (COS) as part of the market authorization procedure, and it takes on the role of a dibasic sodium phosphate, anhydrous CEP holder for the record. Additionally, the data presented in the dibasic sodium phosphate, anhydrous CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the dibasic sodium phosphate, anhydrous DMF.
A dibasic sodium phosphate, anhydrous CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. dibasic sodium phosphate, anhydrous CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of dibasic sodium phosphate, anhydrous suppliers with CEP (COS) on PharmaCompass.